Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2'OMe Modified Pseudouridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119431334A details a high-yield synthesis of 2'OMe pseudouridine. This method offers significant cost reduction and supply chain reliability for mRNA manufacturing.